U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Selection of CD22-Specific Aptamer and its Future Application as a Biotechnological Tool for Diagnosis and Therapy for B- Acute Lymphoblastic Leukemia.
Selection of CD22-Specific Aptamer and its Future Application as a Biotechnological Tool for Diagnosis and Therapy for B- Acute Lymphoblastic Leukemia.